A venture capital and private equity firm investing in companies operating in the life science industry.
Caxton Advantage Life Sciences Fund has made 13 investments, 5 lead investments, and 5 exits. Notable investments made by the firm include: Sunesis Pharmaceuticals (exit), Anthera Pharmaceuticals (exit), Regado Biosciences (exit), Gemi X Pharmaceuticals (exit), Corthera (exit), and Mevion Medical Systems.
Caxton Advantage Life Sciences Fund has made 13 investments, 5 lead investments, and 5 exits. Notable investments made by the firm include: Sunesis Pharmaceuticals (exit), Anthera PharmaceuticalsAnthera Pharmaceuticals (exit), Regado Biosciences (exit), Gemi X Pharmaceuticals (exit), Corthera (exit), and Mevion Medical Systems.
Caxton Advantage Life Sciences Fund is a venture capital and private equity firm investing in companies operating in the life science industry that is headquartered in New York CityNew York City, New York.
Caxton Advantage Life Sciences Fund has made 13 investments, 5 lead investments, and 5 exits. Notable investments made by the firm include: Sunesis Pharmaceuticals (exit), Anthera Pharmaceuticals (exit), Regado BiosciencesRegado Biosciences (exit), Gemi X Pharmaceuticals (exit), Corthera (exit), and Mevion Medical Systems.
Caxton Advantage Life Sciences Fund has made 13 investments, 5 lead investments, and 5 exits. Notable investments made by the firm include: Sunesis Pharmaceuticals (exit), Anthera Pharmaceuticals (exit), Regado Biosciences (exit), Gemi X Pharmaceuticals (exit), Corthera (exit), and Mevion Medical SystemsMevion Medical Systems.
Caxton Advantage Life Sciences Fund has made 13 investments, 5 lead investments, and 5 exits. Notable investments made by the firm include: Sunesis Pharmaceuticals (exit), Anthera Pharmaceuticals (exit), Regado Biosciences (exit), Gemi X Pharmaceuticals (exit), CortheraCorthera (exit), and Mevion Medical Systems.
A venture capital and private equity firm investing in companies operating in the life science industry.
Caxton Advantage Life Sciences Fund is a venture capital and private equity firm investing in companies operating in the life science industry that is headquartered in New York City, New York.
Caxton Advantage Life Sciences Fund has made 13 investments, 5 lead investments, and 5 exits. Notable investments made by the firm include: Sunesis Pharmaceuticals (exit), Anthera Pharmaceuticals (exit), Regado Biosciences (exit), Gemi X Pharmaceuticals (exit), Corthera (exit), and Mevion Medical Systems.
A venture capital and private equity firm investing in companies operating in the life science industry.